CCI
NVRO

Columbus Circle Investors’s NEVRO CORP. NVRO Stock Holding History

Columbus Circle Investors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-35,738
Closed -$3.25M – 280
2017
Q3 		$3.25M Sell
35,738
-5,126
-13% -$439K 0.06% 197
2017
Q2 		$3.04M Sell
40,864
-593,463
-94% -$47.5M 0.05% 186
2017
Q1 		$59.4M Buy
634,327
+102,341
+19% +$9.27M 0.84% 41
2016
Q4 		$38.7M Sell
531,986
-192,093
-27% -$16.4M 0.5% 64
2016
Q3 		$75.6M Sell
724,079
-333,049
-32% -$30.1M 0.82% 39
2016
Q2 		$78M Buy
1,057,128
+162,109
+18% +$11M 0.78% 42
2016
Q1 		$50.4M Buy
895,019
+122,938
+16% +$7.25M 0.45% 62
2015
Q4 		$52.1M Buy
772,081
+433,013
+128% +$23.2M 0.42% 64
2015
Q3 		$15.7M Sell
339,068
-726,211
-68% -$35.2M 0.13% 152
2015
Q2 		$57.3M Buy
1,065,279
+452,272
+74% +$23M 0.4% 62
2015
Q1 		$29.4M Buy
613,007
+603,749
+6,521% +$26.2M 0.2% 115
2014
Q4 		$358K Buy
+9,258
New +$292K ﹤0.01% 281

Other funds holding NVRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Columbus Circle Investors's NVRO Position: Q4 2017 in Review

Columbus Circle Investors sold out of NEVRO CORP. (NVRO) in Q4 2017, closing a stake of 35,738 shares — an estimated $3.25M sold.

Columbus Circle Investors first reported a position in NVRO in Q4 2014 and held it in 12 quarters. The position peaked at $78M in Q2 2016. 194 funds tracked by Wall St. Rank hold NVRO as of Q4 2017.

  • Columbus Circle Investors reported no remaining NEVRO CORP. position as of Q4 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 35,738 NEVRO CORP. shares in Q4 2017, an estimated $3.25M.
  • Columbus Circle Investors first reported a position in NEVRO CORP. in Q4 2014 and held it in 12 quarters.
  • Columbus Circle Investors's NEVRO CORP. position peaked at $78M in Q2 2016.
  • 194 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2017.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.